BioSpace News Archive

Implantable pulse generator (IPG) is a medical device, which consists of a battery, circuitry, can, antenna, reed switch, and connectors.

Argá Medtech announced a featured poster presentation on preliminary findings for its innovative technology at the 2022 Annual Meeting of the Heart Rhythm Society, April 29 to May 1 in San Francisco.

RadNet, Inc. announced that it will host a conference call to discuss its first quarter 2022 financial results on Monday, May 9th, 2022 at 7:30 a.m. Pacific Time.

Gamida Cell Ltd. today announced updated one-year post-transplant data presented on omidubicel at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT), being held in Salt Lake City, UT, April 23-26, 2022.

NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading provider of cancer-focused genetics testing services and global oncology contract research services, today announced its first-quarter results for the period ended March 31, 2022.

Surmodics, Inc. (NASDAQ : SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that its Pounce™ Thrombectomy System achieved 100 percent technical success in 20 First-in-Human (FIH) procedures.

Kura Oncology, Inc. today announced that it will report first quarter 2022 financial results after the close of U.S. financial markets on Wednesday, May 4, 2022.

Alterity Therapeutics today announced that the United Kingdom Medicines & Healthcare products Regulatory Agency (MHRA) has accepted Alterity’s clinical trial authorisation (CTA) request to conduct its Phase 2 clinical trial for ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the BofA Securities 2022 Healthcare Conference on May 11, 2022 at the Encore Hotel in Las Vegas, Nevada.

XVIVO proudly announces the filing of an Investigational Device Exemption application to the US Food & Drug Administration.